English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Jazz Pharmaceuticals
Patient Daily
| May 7, 2023
Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
Patient Daily
| May 7, 2023
Jazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline and Advances in Current Product Portfolio at ASCO 2023
Mifeed
| Apr 27, 2023
Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023
Patient Daily
| Apr 21, 2023
Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
